For the study, researchers examined 2012 data on preeclampsia from numerous population-based and administrative data sets, including the National Center for Health Statistics Vital Statistics on Births database, the U.S. Health Care Cost and Utilization Project database and a commercial claims data set.
Here are four study findings.
- Preeclampsia increases the likelihood of an adverse event from 4.6 percent to 10.1 percent for mothers and from 7.8 percent to 15.4 percent for infants.
- The most common adverse events in mothers were hemorrhaging and low blood platelet counts. Preeclampsia was most closely linked to respiratory distress syndrome and sepsis in infants.
- The condition lowers gestational age by 1.7 weeks.
- Preeclampsia costs the U.S. healthcare system an average of $1.03 billion for mothers and $1.15 billion for infants during the first 12 months after birth.
More articles on infection control and clinical quality:
Pre-op chemo may spur metastasis in breast cancer patients
At-home medication errors double in 13 years
Most Americans prefer paper towels to air dryers after washing hands
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.